Idelalisib (b)
Idelalisib is a selective inhibitor of p110δ (IC50 : 2.5 nM; in cell-free assays) ; shown to have 40- to 300-fold greater selectivity for p110δ than p110α/β/γ, and 400- to 4000-fold more selectivity to p110δ than C2β, hVPS34, DNA-PK and mTOR.
Product Specifications
CAS Number
1146702-54-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
415.42
Molecular Formula
C22H18FN7O
Notes
Research use only, not for human use.
Receptor
P110δ
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
039377 200 µL
OR2W3, CT (OR2W3, OR2W3P, OR2W8P, Olfactory receptor 2W3, Olfactory receptor 2W8, Olfactory receptor OR1-49)
Ask
View Details 
CSB-YP006160SVG-01 20 µg
Recombinant Saccharomyces cerevisiae Cystathionine gamma-lyase (CYS3), partial
Ask
View Details CSB-YP006160SVG-02 100 µg
Recombinant Saccharomyces cerevisiae Cystathionine gamma-lyase (CYS3), partial
Ask
View Details 
CSB-YP006160SVG-03 1 mg
Recombinant Saccharomyces cerevisiae Cystathionine gamma-lyase (CYS3), partial
Ask
View Details